About Zenify
Zenify is a company based in Holywood (United Kingdom) founded in 2020 was acquired by Opentrons in October 2021. Zenify operates in a competitive market with competitors including Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
Investors in Zenify
Zenify has secured backing from 1 investor. Prominent investors backing the company include Opentrons.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pipetting robots for laboratory automation are developed. | 2013 | opentrons.com | Brooklyn, United States |
Investor details for Zenify
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Zenify
2 dated milestones of Zenify across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Zenify is founded.
- Exit Acquired by Opentrons.
Competitors of Zenify
Zenify operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, BioAge Labs, Ingenuity Systems and Cellworks, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. | |
| cellworks.life | 2005 | San Jose, United States | $16.52M | – | Biosimulation platform developed for therapeutic design in life sciences. | |
| genuitysci.com | 2013 | Boston, United States | $515M | – | AI-based omics data analysis solutions are provided to researchers. | |
| ntxbio.com | 2016 | Santa Fe, United States | $74.76M | – | Provider of bio informatics platform to develops biologics and therapeutics | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery |
Detailed competitors of Zenify
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zenify
Complete news archive for Zenify
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Zenify
10 companies that operate in the same segment as Zenify (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Zenify
Zenify was founded in 2020.
Zenify is headquartered in Holywood, United Kingdom. It is registered at Holywood, Northern Ireland, United Kingdom.
Zenith was founded in 2020 and is headquartered in Holywood, United Kingdom. The company operates within the biotechnology sector, where an AI-assisted platform is developed to support the analysis of omics data, including genomics and proteomics. Services are centered on enabling researchers and organizations to process complex datasets efficiently. The platforms domain, zenify.ai, facilitates access to these analytical tools across various applications in life sciences.
Zenify's top competitors include Helix, Benchling and BioAge Labs.
Zenify has 1 investor. Key investors include Opentrons.
Yes. Zenify was acquired by Opentrons in October 2021.